EN
HI
Summary
As of 13 Sep, 2026, Eris Lifesciences stock price is ₹1355.5. During the trading session, the stock has moved between an intraday low of ₹1335.10 and an intraday high of ₹1362.00. Over the last 52 weeks, Eris Lifesciences has traded between ₹1200.00 and ₹1745.00.
The stock has recorded a trading volume of 24,968 shares,. Its Average Traded Price (ATP) is ₹1352.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹1355.50.
Eris Lifesciences has an upper circuit limit of ₹1626.60 and a lower circuit limit of ₹1084.40. The total value traded stands at ₹3.38 CR, and the delivery percentage for the day is 35.22%.
The stock is currently traded with a market lot size of 1. Eris Lifesciences also offers a dividend yield of 0%.
Eris Lifesciences Share Price Chart
Eris Lifesciences Share Key Metrics
Volume
24968.00
Market Cap
18782.79 CR
LTQ@LTP
6@1355.50
ATP
1352.69
Var Margin
15.48 %
Circuit Range
1084.4-1626.6
Delivery %
35.22 %
Value
3.38 CR
ASM/GSM
No
Market Lot
1
Eris Lifesciences Fundamentals
P/E Ratio
29.21
P/B Ratio
4.66
Div. Yield
0
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Eris Lifesciences Resistance and Support
Pivot 1347.5
Resistance
First Resistance
1370
Second Resistance
1383.4
Third Resistance
1405.9
Support
First Support
1334.1
Second Support
1311.6
Third Support
1298.2
Eris Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 1356.6 | 1355.5 | -0.08% | 1362 | 1335.1 |
| Thu Sep 10 2026 | 1335 | 1356.59 | 1.62% | 1360.9 | 1325 |
| Wed Sep 09 2026 | 1318 | 1335 | 0.78% | 1339 | 1318 |
Eris Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-05-20 | Audited Results & Interim Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-24 | Preferential issue of shares |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-07 | Interim Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
Eris Lifesciences News
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Eris Lifesciences will meet institutional investor HBM Partners AG on August 27, 2026. The discussion will cover publicly available documents, with no unpublished price sensitive information intended to be shared.
Aug 24 2026 16:03:52
Eris Lifesciences Management
| Name | Position |
|---|---|
| Milind Talegaonkar | Company Secretary & Compliance Officer |
| Krishnakumar Vaidyanathan | Whole Time Director & COO |
Eris Lifesciences Similar Stocks
Caplin Point Laboratories Ltd.
2754.90
-40.50 (1.45%)
Pfizer Ltd.
4060.20
-35.20 (0.86%)
Astrazeneca Pharma India Ltd.
6764.50
-96.00 (1.40%)
Shilpa Medicare Ltd.
961.15
21.25 (2.26%)
Onesource Specialty Pharma Ltd.
1592.20
50.30 (3.26%)
Poly Medicure Ltd.
1738.50
-9.20 (0.53%)
Cohance Lifesciences Ltd.
440.20
-5.10 (1.15%)
Dr. Agarwal's Health Care Ltd.
508.40
0.05 (0.01%)
Eris Lifesciences FAQs
The Buying Price of Eris Lifesciences share is 1355.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Eris Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eris Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Eris Lifesciences shares is 29.21. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Eris Lifesciences shares is 4.66. Useful to assess the stock's value relative to its book value.
To assess Eris Lifesciences’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Eris Lifesciences is 18782.79 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Eris Lifesciences share price is 1745.00 & 1200.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Eris Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ERIS
